Overview (18 Sep 2026)
Krebs Biochemicals & Industries Ltd
KREBSBIO
INE268B01013
Pharmaceuticals
Result was last declared on 21 May 2026
1.83
Prev. Close
Previous Close
55.48
Current Close
57.31
Current High
62.8
Current Low
55.8
52 Week High
81.8
52 Week Low
38.52
Resistance 1
61.48
Resistance 2
65.64
Support 1
54.48
Support 2
47.48
Std Deviation
3.40%
DMA 200
59.57
DMA 50
55.13
DMA 20
56.11
Fundamentals and Ratios
Standalone
Trailing EPS
0
Forwad EPS
-4.92
Trailing P/E
NA
Forward P/E
NA
PEG Ratio
0.52
Mkt. Cap (Cr)
Market Cap (Cr)
123.56
Total Debt(Cr)
Tot. Debt(Cr)
224.84
Reserve (Cr)
-184.32
Book Value
NA
P/BV Ratio
NA
ROCE(%)
-11.00
ROE
N/A

 

Financial Result
Standalone
TypeJun-26Mar-26Dec-25Sep-25Jun-25FY25-26
Revenue6.986.817.274.175.4823.73
Other Income0.162.000.000.010.012.03
Total Income7.148.817.284.175.4925.76
Interest1.881.911.791.731.657.09
Expenditure-9.62-11.15-10.41-10.32-10.82-42.69
PBDT0.000.000.000.000.000.00
Depreciation-1.59-1.57-1.64-1.62-1.60-6.42
PBT-2.48-2.34-3.13-6.14-5.32-16.93
Tax0.000.000.000.000.000.00
Equity21.5621.560.000.0021.5621.56
OPM-34.73-26.56-42.99-147.42-96.90-65.74
Net Profit-2.48-2.34-3.13-6.14-5.32-16.93
NPM-34.73-26.56-42.99-147.42-96.9-65.74
EPS-1.15-1.09-1.45-2.85-2.470
Consolidated
TypeFY25-26
Revenue23.7316
Other Income2.03
Total Income25.76
Interest7.09
Expenditure-42.69
PBDT0.00
Depreciation-6.42
PBT-16.93
Tax0.00
Equity21.56
OPM-65.74
Net Profit-16.93
NPM-65.74
EPS0
Annual Reports

Corporate Action
Quarterly Result
Dividend
Bonus
Split

Mutual Fund Holddings